REGAN CHRISTENSON: Open Payments
NPI 1548491798 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 55 payments from 11 companies in 2025. Trend: 2023 $886 · 2024 $1,057 · 2025 $1,156
Food & beverage: $1,045Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $302 |
| Alkermes, Inc. | 7 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $150 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Corium, LLC | 4 | $77 |
| Neurocrine BioSciences, Inc. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| ABBVIE INC. | 2 | $48 |
Products named: AUSTEDO XR, CAPLYTA, REXULTI, TRINTELLIX, Azstarys, INGREZZA, LYBALVI, SPRAVATO.
Industry payments across TN — which companies pay providers there.
